Trinity Biotech plc (TRIB) — Long-term Investment Intensity

Latest as of December 2024: 2.4%

Trinity Biotech plc (TRIB) has a Long-term Investment Intensity of 2.4% as of December 2024. Long-term investments of $2.46 Million represent 2.4% of total assets of $103.29 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check TRIB asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

2.4%
LT Investments / Total Assets

Long-term Investments

$2.46 Million
USD

Total Assets

$103.29 Million
USD

Country

USA
NASDAQ

Trinity Biotech plc Long-term Investment Intensity (2014–2024)

This chart shows how Trinity Biotech plc's Long-term Investment Intensity has evolved across 4 annual periods from 2014 to 2024. As of December 2024, the intensity stands at 2.4%, reflecting long-term investments of $2.46 Million against total assets of $103.29 Million USD. For the complete balance sheet picture, see Trinity Biotech plc balance sheet assets.

Annual Long-term Investment Intensity for Trinity Biotech plc (2014–2024)

The table below presents the year-by-year Long-term Investment Intensity for Trinity Biotech plc from 2014 to 2024, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read TRIB current and long-term liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2024 2.4% $2.46 Million $103.29 Million ▲ +2.2 pp
2017 0.2% $360.00K $192.62 Million ▼ -1.1 pp
2015 1.3% $4.69 Million $358.96 Million ▼ -0.6 pp
2014 1.9% $4.69 Million $242.84 Million
pp = percentage points